Thomas Weshefsky
Optometrist · Myrtle Beach, SCNPI 1710997242
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $54,142 of the $77,183 with a category attached, or 70.1%. Oculus, Inc. accounts for 95.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $33,053 and has fallen 91.6% since, to $2,774 in 2025. Among optometrist clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $857.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oculus, Inc.$74K
- Coopervision Inc.$775
- Optos, Inc.$571
- Bausch & Lomb Americas Inc.$486
- Bausch & Lomb, A Division Of Bausch Health US, LLC$270
- Alcon$259
- plus $930 from 9 others
Across 7 payments — averaging $34.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$240
What the payments were for
- Consulting fees$54,14270%
- Speaking & faculty fees$15,45020%
- Travel & lodging$4,3006%
- Food & beverage$3,0334%
- Entertainment$2570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oculus, Inc. | 33 | $73,892 |
| Coopervision Inc. | 15 | $775 |
| Optos, Inc. | 8 | $571 |
| Bausch & Lomb Americas Inc. | 4 | $486 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $270 |
| Alcon | 9 | $259 |
| Glaukos Corporation | 1 | $163 |
| Sight Sciences, Inc. | 2 | $149 |
| Astellas Pharma US Inc | 1 | $124 |
| AbbVie(2 entities) | 2 | $116 |
| Amgen | 1 | $116 |
| Mallinckrodt Hospital Products Inc. | 3 | $106 |
| Sun Pharmaceutical Industries Inc. | 1 | $100 |
| Dompe US, Inc. | 1 | $49 |
| Johnson & Johnson Vision Care, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Keratograph$57,642
- Pentacam$12,000
- OCULUS Keratograph 5M$4,250
- PANORAMIC OPHTHALMOSCOPE$559
- OCT OPHTHALMOSCOPE$405
- MIEBO$363
- NFC-700$280
- XIIDRA$238
- MyDay Contact Lens$234
- TEARCARE SYSTEM$136
- INFUSE$124
- Izervay$124
- VYZULTA$123
- Multiple Brands Contact Lens$118
- TEPEZZA$116
- TRYPTYR$104
How this compares
$77,183 in reported general payments places this provider in the 95th percentile of 653 optometrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 13 | $138 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Myrtle Beach
- Amanda LeeMyrtle Beach$7K
- Lindsey AdamsMyrtle Beach$6K
- Tammy TullyMyrtle Beach$5K
- Richard BedellCharleston$55K
- Patrick VollmerColumbia$49K
- William ColemanEasley$22K
- Furman SmithMt Pleasant$21K
- Jennifer ZolmanCharleston$21K
- Steven AndreasenGreenville$19K
- Bridget WhaleyGreenville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.